Cargando…
Incidence, Clinical Features, Management, and Prevention of Herpes Zoster in Patients Receiving Antitumor Necrosis Factor Therapy: A Clinical Review
Tumor necrosis factor (TNF) inhibitors have been used as an excellent therapeutic option in a variety of chronic inflammatory conditions. However, a recognized significant adverse effect of TNF inhibitor therapy is the increased risk of infections. The influence of TNF inhibitors on the course of co...
Autores principales: | Kim, Byung-Soo, Maverakis, Emanual, Alexanian, Clarie, Wang, Jenny Z., Raychaudhuri, Siba P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238506/ https://www.ncbi.nlm.nih.gov/pubmed/32238066 http://dx.doi.org/10.1177/1203475420914622 |
Ejemplares similares
-
Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
por: Kim, Byungsoo, et al.
Publicado: (2019) -
BIOLOGICAL THERAPY OF PSORIASIS
por: Sivamani, Raja K, et al.
Publicado: (2010) -
The association of family history of herpes zoster and the risk of incident herpes zoster: the SHEZ Study
por: Kinumaki, Keiko, et al.
Publicado: (2022) -
2D Visualization of the Psoriasis Transcriptome Fails to Support the Existence of Dual-Secreting IL-17A/IL-22 Th17 T Cells
por: Le, Stephanie T., et al.
Publicado: (2019) -
Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017)